Mesna (Sagent Pharmaceuticals)


Welcome to the PulseAid listing for the Mesna drug offered from Sagent Pharmaceuticals. This Cytoprotective Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sagent Pharmaceuticals
NON-PROPRIETARY NAME: mesna
SUBSTANCE NAME: MESNA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cytoprotective Agent [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-04-30
END MARKETING DATE: 0000-00-00


Mesna HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMesna from Sagent Pharmaceuticals
LABELER NAME: Sagent Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/mL)
START MARKETING DATE: 2013-04-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 25021-201_a6f2746f-6f3b-435b-bb6b-ec3934624e0e
PRODUCT NDC: 25021-201
APPLICATION NUMBER: ANDA090913

Other MESNA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxter Healthcare CorporationMESNEX
Fresenius Kabi USA, LLCMesna
Mylan Institutional LLCMesna
Sagent PharmaceuticalsMesna
Teva Parenteral Medicines, Inc.Mesna